Document ID: chunk:federal_register_of_legislation:F2016C00224:body:0:p3
Version: federal_register_of_legislation:F2016C00224
Segment Type: other
Provision Reference: 
Character Range: 5124–7940

in the listed chemical product — the weight of 1 active constituent; or
 (b) if there are 2 or more active constituents in the listed chemical product — the total weight of all active constituents in the listed chemical product.
9 Labels
 (1) The label on a container for a listed chemical product must comply with the label format set out in Schedule 1.
 (2) Subject to subsection (3), the only claim about a listed chemical product that may be included on the label of a container for the product is 'long term use may help improve joint health and function', or words to that effect.
 (3) If a listed chemical product also contains vitamins or minerals mentioned in paragraph 7 (1) (a), the label of a container for the product may contain a claim about the vitamins or minerals consisting only of the words 'to supplement diets where levels may be low', or words to that effect.
Schedule 1 Label format
(subsection 9 (1))

FRONT PANEL

CAUTION

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

[PRODUCT NAME]

ACTIVE CONSTITUENT: [Insert the following information:
   (a) the Australian approved name of each active constituent, as described in Subdivision 3.2.1 of Part 3 of Schedule 3B to the Agvet Regulations; and
   (b) the concentration of each active constituent — use mg/kg, g/kg, or mg/capsule/tablet].

[For chondroitin or naturally derived glucosamine – state tissue of origin (eg marine exoskeleton, shark cartilage, bovine cartilage etc)].

OTHER INGREDIENTS: [Insert the concentration and name of each additional constituent of the kind mentioned in section 7(1)(a) — use mg/kg, g/kg, or mg/capsule/tablet].

Long term use may help improve joint health and function. [Or insert words to that effect]

Contents: [Insert net weight or number of tablets/capsules]

ANCILLARY PANEL

DIRECTIONS FOR USE

Not recommended for use in acute or infectious joint conditions. For a diagnosis to determine these conditions, or in the event of adverse experience (eg diarrhoea) or where response is unsatisfactory, consult your veterinarian. Use with caution in pregnant or lactating animals as safe use in these groups has not been established. Use with caution in animals with bleeding, liver or kidney disorders.
[Insert the following information:

   (a) dosage instructions in accordance with section 6; and
   (b) administration instructions consistent with the use information set out in column 3 of item 2 in the table in Part 2 of Schedule 3B to the Agvet Regulations. Give dose in mg/kg body weight followed by discrete dose per weight or weight range as applicable].

USER SAFETY INFORMATION: Avoid inhalation of dust.

[The user safety information need only be included where relevant to the product's formulation type.  For example, it should be included for powders, granules and